Clinical Trial to Evaluate the Efficacy of Gene Therapy for Pyruvate Kinase Deficiency

Clinical trial NCT06422351 · SUSPENDED

Trial details

NCT number: NCT06422351
Sponsor: Rocket Pharmaceuticals Inc.
Status: SUSPENDED
Phase: Phase 2
Study type: INTERVENTIONAL

Pyruvate Kinase Deficiency

Start date: 2026-04-01
Primary completion: 2029-01-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.